The value of extracellular vesicles in the pathogenesis and diagnosis of non-alcoholic fatty liver disease (literature review)

Authors

  • Yu.M. Stepanov State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine
  • O.Yu. Lukianenko State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine http://orcid.org/0000-0002-1758-3981

DOI:

https://doi.org/10.22141/2308-2097.53.4.2019.182408

Keywords:

extracellular vesicles, biomarkers, chronic liver disease

Abstract

Extracellular vesicles (EVs) are small membrane vesicles that are secreted by cells into the extracellular environment. EVs are cell-produced communication molecules that can affect a range of target cells in their cellular environment and may also have a long-range effect. Currently, EVs are considered to be highly sensitive biomarkers of chronic liver diseases. The article gives an overview of the current literature on the role of EVs in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), as well as the diagnostic value of EVs in the context of NAFLD. The article deals with the classification of EVs, the structure of EV, describes molecules that make up EV. Attention is paid to the issues of EV identification in the blood serum. The role of EV in the formation and progression of NAFLD is discussed in detail. The article demonstrates that progression of NAFLD is associated with EVs derived from hepatocytes, as well as extrahepatic and bacterial EVs. It is shown that the value of EV in NAFLD is not limited to the formation of dysmetabolic changes, but includes the development of inflammation and liver fibrosis. On the other hand, EVs can be used as transporters of exogenous RNA molecules to the liver cells. EV-associated ncRNAs are confidently recognized as important regulators of biological processes in both physiological and pathological conditions.

Downloads

Download data is not yet available.

References

Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.

Eguchi A, Kostallari E, Feldstein AE, Shah VH. Extracellular vesicles, the liquid biopsy of the future. J Hepatol. 2019 Jun;70(6):1292-1294. doi: 10.1016/j.jhep.2019.01.030.

Hirsova P, Ibrahim SH, Verma VK, et al. Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology. 2016 Dec;64(6):2219-2233. doi: 10.1002/hep.28814.

Maji S, Matsuda A, Yan IK, Parasramka M, Patel T. Extracellular vesicles in liver diseases. Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G194-G200. doi: 10.1152/ajpgi.00216.2016.

Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol. 2013 Feb 18;200(4):367-71. doi: 10.1083/jcb.201212113.

Lambrecht J, Verhulst S, Mannaerts I, Reynaert H, van Grunsven LA. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard? Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1024-1036. doi: 10.1016/j.bbadis.2018.01.009.

Deng F, Magee N, Zhang Y. Decoding the role of extracellular vesicles in liver diseases. Liver Res. 2017 Sep;1(3):147-155. doi: 10.1016/j.livres.2017.11.003.

Zhang X, Ji X, Wang Q, Li JZ. New insight into inter-organ crosstalk contributing to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Protein Cell. 2018 Feb;9(2):164-177. doi: 10.1007/s13238-017-0436-0.

Yao ZY, Chen WB, Shao SS, et al. Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. J Zhejiang Univ Sci B. 2018 Mar.;19(3):183-198. doi: 10.1631/jzus.B1600490.

Hirsova P, Ibrahim SH, Verma VK, et al. Extracellular vesicles in liver pathobiology: Small particles with big impact. Hepatology. 2016 Dec;64(6):2219-2233. doi: 10.1002/hep.28814.

Ban LA, Shackel NA, McLennan SV. Extracellular vesicles: a new frontier in biomarker discovery for non-alcoholic fatty liver disease. Int J Mol Sci. 2016 Mar 14;17(3):376. doi: 10.3390/ijms17030376.

Pessolano E, Belvedere R, Bizzarro V. Annexin A1 Contained in Extracellular Vesicles Promotes the Activation of Keratinocytes by Mesoglycan Effects: An Autocrine Loop Through FPRs. Cells. 2019 Jul 19;8(7). pii: E753. doi: 10.3390/cells8070753.

Povero D, Eguchi A, Li H, et al. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One. 2014 Dec 3;9(12):e113651. doi: 10.1371/journal.pone.0113651.

Otto GP, Nichols BJ. The roles of flotillin microdomains–endocytosis and beyond. J Cell Sci. 2011 Dec 1;124(Pt 23):3933-40. doi: 10.1242/jcs.092015.

Andreu Z, Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014 Sep 16;5:442. doi: 10.3389/fimmu.2014.00442.

Lozano-Andrés E, Libregts SF, Toribio V, et al. Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material. J Extracell Vesicles. 2019 Mar 4;8(1):1573052. doi: 10.1080/20013078.2019.1573052.

Pfeffer SR. Two Rabs for exosome release. Nat Cell Biol. 2010 Jan;12(1):3-4. doi: 10.1038/ncb0110-3.

Lorenz L, Axnick J, Buschmann T, et al. Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival. Nature. 2018 Oct;562(7725):128-132. doi: 10.1038/s41586-018-0522-3.

Bartucci R, Salvati A, Olinga P, Boersma YL. Vanin 1: Its Physiological Function and Role in Diseases. Int J Mol Sci. 2019 Aug 9;20(16). pii: E3891. doi: 10.3390/ijms20163891.

Povero D, Eguchi A, Niesman IR, et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells. Sci Signal. 2013 Oct 8;6(296):ra88. doi: 10.1126/scisignal.2004512.

Yang J, Li C, Zhang L, Wang X. Extracellular vesicles as carriers of non-coding RNAs in liver diseases. Front Pharmacol. 2018 Apr 24;9:415. doi: 10.3389/fphar.2018.00415.

Roderburg C, Luedde T. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. J Hepatol. 2014 Dec;61(6):1434-7. doi: 10.1016/j.jhep.2014.07.017.

Arrese M, Eguchi A, Feldstein AE. Circulating microRNAs: emerging biomarkers of liver disease. Semin Liver Dis. 2015 Feb;35(1):43-54. doi: 10.1055/s-0034-1397348.

Falcon-Perez JM, Royo F. Circulating RNA: looking at the liver through a frosted glass. Biomarkers. 2015;20(6-7):339-54. doi: 10.3109/1354750X.2015.1101785.

Rodríguez-Suárez E, Gonzalez E, Hughes C, et al. Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity. J Proteomics. 2014 May 30;103:227-40. doi: 10.1016/j.jprot.2014.04.008.

Giroud M, Scheideler M. Long Non-coding RNAs in metabolic organs and energy homeostasis. Int J Mol Sci. 2017 Nov 30;18(12). pii: E2578. doi: 10.3390/ijms18122578.

Carlevaro CM, Irastorza RM, Vericat F. Quaternionic representation of the genetic code. Biosystems. 2016 Mar;141:10-9. doi: 10.1016/j.biosystems.2015.12.009.

Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019.

Malizia, AP, Wang DZ. MicroRNAs in cardiomyocyte development. Wiley Interdiscip Rev Syst Biol Med. 2011 Mar-Apr;3(2):183-90. doi: 10.1002/wsbm.111.

Hardy T, Zeybel M, Day CP, et al. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut. 2017 Jul;66(7):1321-1328. doi: 10.1136/gutjnl-2016-311526.

Eguchi A, Lazaro RG, Wang J, et al. Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood. Hepatology. 2017 Feb;65(2):475-490. doi: 10.1002/hep.28838.

JR Shadway UEG image Hub.

Huang-Doran I, Zhang CY, Vidal-Puig A. Extracellular vesicles: novel mediators of cell communication in metabolic disease. Trends Endocrinol Metab. 2017 Jan;28(1):3-18. doi: 10.1016/j.tem.2016.10.003.

Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015 May 14;4:27066. doi: 10.3402/jev.v4.27066.

Royo F, Moreno L, Mleczko J, et al. Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism. Sci Rep. 2017 Feb 17;7:42798. doi: 10.1038/srep42798.

Kornek M, Lynch M, Mehta SH, et al. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology. 2012 Aug;143(2):448-58. doi: 10.1053/j.gastro.2012.04.031.

Eguchi, A, Feldstein, AE. Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. Liver Res. 2018 Mar;2(1):30-34. doi: 10.1016/j.livres.2018.01.001.

Kornek M, Popov Y, Libermann TA, Afdhal NH, Schuppan D. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology. 2011 Jan;53(1):230-42. doi: 10.1002/hep.23999.

Ji Y, Yin Y, Li Z, Zhang W. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2019 Jul 25;11(8). pii: E1712. doi: 10.3390/nu11081712.

Tulkens J, Vergauwen G, Van Deun J, et al. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction. Gut. 2018 Dec 5. pii: gutjnl-2018-317726. doi: 10.1136/gutjnl-2018-317726.

Anand D, Chaudhuri A. Bacterial outer membrane vesicles: New insights and applications. Mol Membr Biol. 2016 Sep - Dec;33(6-8):125-137. doi: 10.1080/09687688.2017.1400602.

Rani S, Ryan AE, Griffin MD, Ritter T. Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther. 2015 May;23(5):812-823. doi: 10.1038/mt.2015.44.

Phinney DG, Di Giuseppe M, Njah J, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015 Oct 7;6:8472. doi: 10.1038/ncomms9472.

Downloads

Published

2021-09-06

How to Cite

Stepanov, Y., & Lukianenko, O. (2021). The value of extracellular vesicles in the pathogenesis and diagnosis of non-alcoholic fatty liver disease (literature review). GASTROENTEROLOGY, 53(4), 282–290. https://doi.org/10.22141/2308-2097.53.4.2019.182408

Issue

Vol. 53 No. 4 (2019)

Section

Reviews and Lections

License

Copyright (c) 2019 Yu.M. Stepanov, O.Yu. Lukianenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>